HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer
Yiran Liang(Qilu Hospital of Shandong University), Qifeng Yang(Qilu Hospital of Shandong University), Dianwen Han(Qilu Hospital of Shandong University), Xiaoli Kong(Qilu Hospital of Shandong University), Fangzhou Ye(Fudan University), Xi Chen(Nutrasource), Bing Chen(Shanghai Medical College of Fudan University), Yajie Wang(Qilu Hospital of Shandong University), Yan Zhang(Huaqiao University), Yaming Li(Qilu Hospital of Shandong University), Zekun Wang(Qilu Hospital of Shandong University), Dan Luo(Qilu Hospital of Shandong University), Wenjing Zhao(Xinjiang Uygur Autonomous Region Product Quality Supervision and Inspection Institute), Lijuan Wang(Xuzhou University of Technology), Tingting Ma(Qilu Hospital of Shandong University), Yuhan Jin(Qilu Hospital of Shandong University)
Cited by 112
Related Papers
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215
|Journal of Cellular Physiology|2018|301
Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell
|Chemical Science|2020|245